XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
150 hedge funds and large institutions have $1.59B invested in Acceleron Pharma in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
67% less call options, than puts
Call options by funds: $3.33M | Put options by funds: $10.2M
Holders
150
Holding in Top 10
2
Calls
$3.33M
Puts
$10.2M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$13M | |
| 3 | +$12.2M | |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$11.4M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.3M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$19.1M | |
| 3 | -$8.49M | |
| 4 |
First Manhattan
New York
|
-$6.43M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.34M |